Qinprezo
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Qinprezo, covering 2017-08-15 to 2017-08-15. Get the full timeline:
Most recent: EMA Application withdrawn: Qinprezo (vosaroxin) — Sunesis Europe Ltd